SCHEMBL14198112

SCHEMBL14198112

C/N=N/c1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.72
▸ THRB P10828 4/20 0.72
▸ HPGD P15428 4/20 0.72
▸ RECQL P46063 4/20 0.72
▸ KMT2A Q03164 4/20 0.72
▸ KDM4E B2RXH2 3/20 0.72
▸ CYP3A4 P08684 3/20 0.72
▸ MAPK1 P28482 3/20 0.72
▸ HSD17B10 Q99714 3/20 0.72
▸ ALDH1A1 P00352 3/20 0.72
▸ MAPT P10636 3/20 0.72
▸ BLM P54132 3/20 0.72
▸ TP53 P04637 2/20 0.72
▸ ALOX15 P16050 2/20 0.72
▸ BRCA1 P38398 2/20 0.72
▸ CYP2C9 P11712 2/20 0.72
▸ CYP2C19 P33261 2/20 0.72
▸ APP P05067 2/20 0.72
▸ SNCA P37840 2/20 0.72
▸ CYP2D6 P10635 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14148445 0.84 CYP1A2 (0.84) MEN1THRBHPGDRECQLKMT2A
SCHEMBL14188878 0.84 MEN1 (0.83) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL30337894 0.84 MEN1 (1.00) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL31658969 0.84 MEN1 (1.00) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL29518427 0.84 MEN1 (1.00) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL16572423 0.84 MEN1 (1.00) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL14533441 0.84 MEN1 (1.00) MEN1THRBHPGDRECQLKMT2A
SCHEMBL17791868 0.83 CYP1A2 (0.77) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL5859460 0.83 MEN1 (0.98) MEN1THRBHPGDRECQLKMT2A
Evans Blue Free Acid SCHEMBL29609615 0.83 MEN1 (0.98) MEN1THRBHPGDRECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080087549-A1 Additive For Copper Plating And Process For Producing Electronic Circiut Substrate Therewith EBARA-UDYLITE CO.,LTD. (JP) 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080087549-A1 Additive For Copper Plating And Process For Producing Electronic Circiut Substrate Therewith AOC2, SCO2, NOXO1 MEN1 645/4885THRB 2815/4885HPGD 2235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback